ArticleJournal of medicinal chemistry2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation.
Brian T Hopkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.